EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Harmonization and integration of pharmacogenomics screens

Aleysha T Chen, Marcus R Kelly, Trey Ideker iD, Nicole M Mattson iD

Bioinformatics · 02.07.2026 · 42 (7)

DOI: 10.1093/bioinformatics/btag382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 12.06.2026. Verfasst von Aleysha T Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of California, San Diego, San Diego, CA 92093, United States. Hauptthemen laut MEDLINE: Pharmacogenetics, Pharmacogenomic Testing. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, U.S. government, Cancer Biology, Informatics & Omics Training (CBIO).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation Large pharmacogenomics screens have generated a wealth of information cataloguing the responses of more than a thousand tumor cell-line models to FDA-approved and exploratory drugs. Although centralized repositories have consolidated data access, the diversity of experimental platforms and response metrics used in these screens have made it challenging to integrate and compare their measured drug responses. Towards better pharmacogenomic data harmonization, we surveyed a range of data analysis protocols based on different curve-fitting functions (sigmoid, piecewise linear), different response metrics (IC50, EC50, integrated AUC), and different drug concentration windows (full range or truncated). Results We found that an AUC derived from a sigmoidal curve fitted to a truncated dose range yields the strongest agreement between screening platforms, significantly bettering other protocols surveyed. This harmonization procedure also best aligns drug responses across successive iterations of the same platform. These findings broadly inform efforts to integrate drug response data in large-scale analyses. Availability The source code to generate drug response profiles and correlations are available at https://github.com/digitaltumors/Pharmacogenomics_Screens_Harmonization.git.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacogeneticsPharmacogenomic TestingHumansCell Line, Tumor

Autor:innen und Institutionen

  • Department of Bioengineering, University of California, San Diego, San Diego, CA 92093, United States.
  • Department of Medicine, University of California, San Diego, San Diego, CA 92093, United States.
  • Moores Cancer Center, University of California, San Diego, San Diego, CA 92093, United States.
  • Department of Computer Science and Engineering, University of California, San Diego, San Diego, CA 92093, United States.

ORCID-Profile: Trey Ideker, Nicole M Mattson

Förderung

  • NCI NIH HHS
  • U.S. government
  • Cancer Biology, Informatics & Omics Training (CBIO)
  • ARPA-H ADAPT
  • National Institutes of Health
  • the Cancer Cell Map Initiative

Zitieren

APA

Chen, A. T., Kelly, M. R., Ideker, T., & Mattson, N. M. (2026). Harmonization and integration of pharmacogenomics screens. Bioinformatics, 42(7). https://doi.org/10.1093/bioinformatics/btag382

Vancouver

Chen AT, Kelly MR, Ideker T, Mattson NM. Harmonization and integration of pharmacogenomics screens. Bioinformatics. 2026;42(7). doi:10.1093/bioinformatics/btag382

BibTeX
@article{Chen2026,
  author = {Chen, Aleysha T and Kelly, Marcus R and Ideker, Trey and Mattson, Nicole M},
  title = {Harmonization and integration of pharmacogenomics screens},
  journal = {Bioinformatics},
  year = {2026},
  volume = {42},
  number = {7},
  doi = {10.1093/bioinformatics/btag382}
}
Kostenlos starten →